SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group Inc. (OTCBB: BMSN), a biotechnology company focused on stem cell cryogenics and disposable stem cell/tissue transfer instruments, announced today that it has entered into the facility validation process. This process focuses on the validation of systems and equipment involved in the manufacturing of both medical devices and cellular products.
